Showing 161 - 180 results of 14,123 for search '(( 5 mm decrease ) OR ( 100 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 0.51s Refine Results
  1. 161

    Alternative bounded and monotonically decreasing functions do not accurately fit the bias in the naïve SI. by Liron Sheintuch (12078310)

    Published 2022
    “…Data in A-C show the mean across 100 cells from one example simulation. …”
  2. 162

    Performance of the response detection algorithm at detecting simulated increases versus decreases in firing rate. by Bettina C. Schwab (9515382)

    Published 2020
    “…<p>Curves reflect the mean (±SD) fraction of increases and decreases detected as a function of the simulated response size (expressed as percent of baseline firing rate). …”
  3. 163
  4. 164
  5. 165

    Decreased projections to LP in <i>Brn3b</i> mutants occur postnatally. by Hyoseo Lee (17419987)

    Published 2023
    “…(<b>D</b>) Quantification was presented as a relative difference between the AP-covered LP area in controls and mutants (1.00 ± 0.07 for control, 0.20 ± 0.03 for cKO; <i>n</i> = 4 mice/group). …”
  6. 166
  7. 167
  8. 168

    Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

    Published 2021
    “…Right panels; enteroendocrine cells stained with chromogranin A antibody (brown; arrowheads) in the villi. Scale bars are 100 μm. …”
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173

    Mylipb decreases tbk1-mediated irf3 phosphorylation and cellular antiviral response. by Zhi Li (72309)

    Published 2024
    “…<p>(A) Overexpression of <i>mylipb</i>-WT and <i>mylipb</i>-C381S inhibits tbk1-mediated phosphorylation of irf3. …”
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…<p>Cell lysates were obtained from THP-1 monocytes exposed to reagents as indicated: Lane 1, vehicle; Lane 2, PARP inhibitor olaparib (5 mM, 24 hr); Lane 3, oxLDL (100 mg/mL, 24 hr) or Lane 4, combination of oxLDL and olaparib. …”
  19. 179
  20. 180